CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
14.14
1.74%
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.10
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 14.39
Open 14.31
1-Year Change -8.62%
Day's Range 14.02 - 14.66
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 21, 2025 14.14 -0.07 -0.49% 14.21 14.71 14.01
Jan 17, 2025 14.15 0.19 1.36% 13.96 14.53 13.96
Jan 16, 2025 13.93 -0.61 -4.20% 14.54 14.54 13.88
Jan 15, 2025 14.65 -0.05 -0.34% 14.70 16.02 14.44
Jan 14, 2025 13.72 1.11 8.80% 12.61 13.82 12.20
Jan 13, 2025 12.58 -1.47 -10.46% 14.05 14.14 12.07
Jan 10, 2025 14.69 -2.77 -15.86% 17.46 17.63 14.47
Jan 8, 2025 18.56 0.57 3.17% 17.99 19.07 17.98
Jan 7, 2025 18.31 0.56 3.15% 17.75 18.31 17.51
Jan 6, 2025 17.62 0.78 4.63% 16.84 17.62 16.84
Jan 3, 2025 16.90 0.57 3.49% 16.33 17.05 16.33
Jan 2, 2025 16.43 -0.01 -0.06% 16.44 16.86 16.27
Dec 31, 2024 16.44 -0.54 -3.18% 16.98 17.10 16.42
Dec 30, 2024 16.87 0.44 2.68% 16.43 16.87 16.31
Dec 27, 2024 16.77 -0.04 -0.24% 16.81 17.13 16.64
Dec 26, 2024 17.22 0.65 3.92% 16.57 17.32 16.57
Dec 24, 2024 17.10 0.63 3.83% 16.47 17.11 16.11
Dec 23, 2024 16.49 0.32 1.98% 16.17 16.66 16.11
Dec 20, 2024 16.36 0.20 1.24% 16.16 16.54 16.16
Dec 19, 2024 16.33 -0.06 -0.37% 16.39 16.76 16.18

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

NeoGenomics Company profile

About NeoGenomics, Inc.

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories. The Company operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. It offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. It operates testing laboratories in United States, Europe and Asia.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, NeoGenomics, Inc. revenues increased 9% to $484.3M. Net loss totaled $8.3M vs. income of $4.2M. Revenues reflect Clinical Services segment increase of 6% to $404.2M, Pharma Services segment increase of 29% to $80.2M. Net loss reflects General and administrative increase of 38% to $167.2M (expense), Sales and marketing increase of 31% to $62.6M (expense).

Equity composition

Common Stock $0.001 Par, 03/12, 100M auth., 43,236,498. issd. Insiders own approx. 46.49%.

Industry: Medical & Diagnostic Laboratories

9490 Neogenomics Way
FORT MYERS
FLORIDA 33912
US

People also watch

BTC/USD

104,932.30 Price
-1.730% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

XRP/USD

3.21 Price
+0.860% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01599

ETH/USD

3,307.17 Price
-0.710% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,755.75 Price
+0.550% 1D Chg, %
Long position overnight fee 0.0110%
Short position overnight fee -0.0193%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 680,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading